Reprogramming the Immune System to Target Cancer: Chimeric Antigen Receptor T-Cell Therapy
An emerging immunotherapy technique uses patients’ own T-cells to develop a personalized, targeted anticancer treatment. This review discusses the CAR T-cell process, and the nurses’ role in recognizing and managing its toxicities.
